Calcific Tendinitis: Comparing Minimally Invasive Modalities

• Status: Recruiting
• Trial end date: 2022-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Calcific tendinitis is a common and challenging problem in the orthopedic surgeon's office. The chronic and variable course of the condition can lead to dissatisfaction with conservative management. Current standard of care at the Thunder Bay Regional Health Sciences Centre is referral for treatment by either needle decompression therapy by a radiologist or shockwave therapy by a physiotherapist. The purpose of this study is to compare the efficacies of these treatment options.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lakehead University
• Treatments: Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• New diagnosis of symptomatic calcific tendinitis of the shoulder

• Seeking treatment for diagnosis

• ≥ 18 years of age

Exclusion Criteria:

• Pre-existing diagnosis of rotator cuff tear or arthropathy

• Previous minimally invasive or surgical therapy

• Systemic Inflammatory disease

• Blood dyscrasia

• Peripheral neuropathy

• Active Workplace Safety & Insurance Board (WSIB) claim for shoulder injury